Hydrochlorothiazide Capsule
Product Images NDC 62332-070

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 62332-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrochlorothiazide 125mg

Hydrochlorothiazide 125mg
This is a description of a medication in capsule form that contains Hydrochlorothiazide and ISP 125. The packaging states the National Drug Code and other code numbers for reference. The capsules are also identified as Depere, Seengisteze and Kolramicouicas Lioid RXONY 30 Capsules. The expiration date and lot number are printed for reference, along with Balch coding and barcode.*
FDA Label Image

Structure (Hydrochlorothiazide Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.